Learning outcomes
By the end of this lesson you should be able to: describe the three classes of innate barrier — anatomical, chemical and microbiological — with named examples of each; explain how pattern-recognition receptors distinguish conserved microbial structures from self, and name the ligands of Toll-like receptors 2, 3, 4 and 5; describe the complement cascade by its entry route, its three effectors of elimination and its regulator CR1; describe phagocytosis and killing, including the respiratory burst and the defect that causes chronic granulomatous disease; describe natural killer cell killing and the 'missing self' principle; and explain inflammation as a local response and the acute-phase response as its systemic counterpart.
Prerequisites
Module 1 — bacterial cell structure and genetics. Innate immunity recognises exactly the structures you have studied: lipopolysaccharide, peptidoglycan, flagellin and double-stranded RNA are the signatures of the walls and genomes you have already met.
The big idea
Adaptive immunity is extraordinary, but it is slow: days to build a receptor and more days to expand it. Innate immunity is what keeps you alive in the meantime, and it works by recognising the category of the invader rather than the identity of the strain. Its receptors have been hard-wired by evolution to notice things that no microbe can afford to lose — lipopolysaccharide on the Gram-negative envelope, peptidoglycan shared by nearly all bacteria, double-stranded RNA made only in viral replication — so the pathogen cannot simply mutate to escape, as it can from a single antibody.
Innate immunity is therefore not the crude 'first line' of a textbook diagram; it is the determinant of whether adaptive immunity ever gets started. The receptor that triggers a dendritic cell to mature also enables it to present antigen and release the cytokines that decide whether a T-cell response becomes Th1 or Th2. An innate response that fails to fire gives no adaptive response either — which is why some immune deficiencies present as repeated infection despite normal antibody counts.
Barriers: the first line
| Class | Examples | Mechanism of defence | What loss looks like |
|---|---|---|---|
| Anatomical | Skin, mucosae of gut, respiratory and genitourinary tracts, conjunctiva, gut epithelium | A mechanical wall of keratinised cells and tight junctions that microbes cannot cross; mucus traps them; cilia sweep them out | Burns, indwelling catheters and cystic fibrosis all defeat this layer, and infection follows |
| Chemical | Fatty acids and sweat, saliva lysozyme, gastric acid, surfactant proteins, defensins, lactoferrin | Direct killing or growth inhibition — gastric acid kills most swallowed bacteria, lactoferrin starves iron-dependent organisms, defensins punch holes in membranes | Achlorhydria, proton-pump inhibitors and antibiotics all disturb the ecology and permit colonisation |
| Microbiological | Commensal flora of skin, mouth, gut and vagina | Competition for nutrients and adhesion sites, and production of bacteriocins and volatile acids that suppress pathogens | Broad-spectrum antibiotics destroy the flora and allow Candida and Clostridioides difficile to fill the vacuum |
NoteThe stomach alone demonstrates the value of a chemical barrier: gastric acid at pH 2 kills most ingested bacteria within minutes, which is why Vibrio cholerae needs a large inoculum and why persons taking proton-pump inhibitors have measurably more enteric infections. Helical and flagellated organisms such as Helicobacter pylori survive it by burrowing into mucus and secreting urease.
Pattern recognition: how innate immunity sees a microbe
The receptors that read these signatures are germline-encoded pattern-recognition receptors: Toll-like receptors on the cell surface and in endosomes, C-type lectins that recognise fungal mannans, NOD-like receptors that read peptidoglycan fragments in the cytosol, and RIG-I-like receptors that read viral RNA. Their ligands are the envelope components of module 1 and the nucleic acids of module 3.
| Receptor | Location | Recognises | Signalling result | Clinical consequence of defect |
|---|---|---|---|---|
| TLR1/2 (heterodimer) | Cell surface | Lipopeptides, peptidoglycan, lipoteichoic acid | NF-kB activation and inflammatory cytokines | Increased susceptibility to Gram-positive infection |
| TLR4 | Cell surface | Lipopolysaccharide, with CD14 and MD-2 as co-receptors | A very strong inflammatory cascade; the receptor for endotoxin | TLR4 mutations give blunted responses to endotoxin and altered sepsis risk |
| TLR5 | Cell surface | Flagellin | NF-kB and chemokine production | Increased risk of Legionella pneumonia, since flagellin drives the response |
| TLR3 | Endosome | Double-stranded RNA, made during viral replication | Type I interferon production via TRIF | Impaired antiviral response, notably to herpes simplex encephalitis |
| TLR7 and TLR8 | Endosome | Single-stranded RNA and guanosine analogues | Type I interferon and interleukin-12; the target of imiquimod and hydroxychloroquine | Defects predispose to severe influenza and COVID-19 |
| TLR9 | Endosome | Unmethylated CpG dinucleotides characteristic of bacterial DNA | Interleukin-12 and interferon-alpha; the adjuvant effect of CpG oligonucleotides | Altered response to DNA-adjuvanted vaccines |
NoteEndosomal location is a deliberate safeguard. By placing TLR3, 7 and 9 inside the cell rather than on the surface, the innate system only encounters nucleic acids after the microbe has been engulfed and digested, which prevents a harmless self-nucleic acid in serum from triggering autoimmunity. The price is a disease: TLR7/9 defects, and the systemic lupus-like disease of TREX1 deficiency, follow from failure to distinguish self nucleic acids properly.
Complement: an innate cascade with wide consequences
The complement cascade has three entry routes. The classical route is triggered by antibody (C1q binding to the Fc region of IgM or aggregated IgG), so it belongs to adaptive immunity but is mediated by an innate protein. The lectin route is triggered by mannose-binding lectin or ficolins binding microbial carbohydrate, with MASP enzymes activating C4 and C2. The alternative route is spontaneous and continuous: C3 thioester hydrolysis ('tick-over') deposits C3b on any nearby surface, and microbial surfaces lack the complement regulators that would destroy it, so amplification continues there.
| Pathway | Trigger | First component activated | Roles |
|---|---|---|---|
| Classical | Antigen–antibody complex: C1q binds IgM or IgG Fc | C1q, then C1r, C1s, C4, C2 | Effector of the adaptive response; measured in CH50 functional assays |
| Lectin | Mannose-binding lectin or ficolin bound to microbial sugars | MASP-1 and MASP-2, then C4, C2 | Independent of antibody, and impaired by the common MBP gene mutation |
| Alternative | Spontaneous C3 hydrolysis and microbial surface binding | C3b, factor B, factor D | The amplification loop — it generates most of the C3b and C5b |
| Terminal (common) | C3 convertase activity and C5 cleavage | C5, C6, C7, C8, C9 | The membrane attack complex, which lyses bacteria by drilling holes in the membrane |
Once activated, complement eliminates in three ways. C3b is an opsonin that coats the microbe and is eaten by phagocytes bearing complement receptors; C3a and C5a are anaphylatoxins that degranulate mast cells and recruit neutrophils (and, at C5a levels, cause the shock picture of meningococcaemia); and C5b–C9 form the membrane attack complex, a cylinder of several complement components inserted into the membrane, which kills Gram-negative bacteria but which cannot easily attack Gram-positive ones because their wall is too thick.
Watch outComplement deficiency is the counterintuitive exception to 'immune deficiency means repeated infection'. Deficiencies of the early components — C1q, C2, C4 — cause systemic lupus erythematosus, because the complement system normally clears immune complexes. Deficiencies of the late components (C5–C9) cause recurrent Neisseria infection, because only the membrane attack complex reliably destroys Neisseria meningitidis and Neisseria gonorrhoeae. A patient with recurrent meningococcal sepsis must be screened for terminal complement deficiency.
Phagocytes and killing
Phagocytes are the cell-bound arm of innate immunity. Neutrophils arrive first — within six to eight hours — and are short-lived; macrophages follow later, persist in tissues and do the clearing up; dendritic cells interrogate antigen and carry it to lymph nodes to start the adaptive response. All three engulf an opsonised particle into a phagosome, which fuses with lysosomal granules to make a phagolysosome, and all three kill with oxygen-dependent and oxygen-independent mechanisms.
| Killing mechanism | How it works | Consequence of failure |
|---|---|---|
| Respiratory burst | NADPH oxidase transfers electrons to oxygen to make superoxide, which dismutates to hydrogen peroxide | Chronic granulomatous disease (X-linked) — recurrent catalase-positive infections and granulomas |
| Myeloperoxidase | Uses hydrogen peroxide and chloride to make hypochlorous acid, the most efficient neutrophil bactericide | Blunted killing, but usually clinically silent because other pathways compensate |
| Defensins and lactoferrin | Antimicrobial peptide damage and iron sequestration | Rare single-gene defects with mild phenotypes |
| Low pH and lysosomal enzymes | Proteases and hydrolases digest the engulfed and killed organism | Chédiak–Higashi syndrome: giant granules and defective degranulation |
NoteNeutrophil extracellular traps explain a puzzle: how does a neutrophil kill organisms it cannot engulf, such as a fungal hypha that is many times its own diameter? It decondenses its chromatin, mixes it with granule enzymes and extrudes it as a web that traps and kills the filament. DNase treatment dissolves these traps, which is why DNase is an inhaled therapy in cystic fibrosis.
Natural killer cells and the missing self
Natural killer cells are large granular lymphocytes that kill without prior sensitisation, using the same perforin–granzyme and Fas-FasL machinery that cytotoxic T cells use. Their specificity comes from a negative rule: they express inhibitory receptors for MHC class I, and any cell that displays normal MHC class I is spared. A cell that has lost MHC class I — a virally infected cell or a tumour cell — loses the inhibitory signal and is killed.
This is why NK cells matter in herpesvirus infection specifically. Cytomegalovirus and others encode proteins that downregulate MHC class I to hide from CD8 T cells — a strategy that works for cytotoxic T cells but leaves the cell exposed to natural killing, because the missing MHC class I is exactly the signal the NK inhibitory receptor was looking for. Viral decoy mechanisms such as MHC-I homologues that engage inhibitory receptors are the counter-countermeasure.
Inflammation and the acute-phase response
| Event | Mediator | Effect | Clinical reading |
|---|---|---|---|
| Vasodilation | Histamine, prostaglandins, nitric oxide | Redness and heat of the inflamed tissue | Erythema — the cardinal bedside sign |
| Increased permeability | Histamine, bradykinin, leukotrienes | Exudate of protein-rich fluid into tissue | Swelling and pain from tissue tension |
| Neutrophil recruitment | C5a and leukotriene B4 chemotaxis, selectin and integrin adhesion | Leukocyte margination, rolling, and exit through vessel wall | Neutrophils predominate in the first six hours, pus is their residue |
| Fever | Interleukin-1, interleukin-6 and tumour necrosis factor acting on the hypothalamus | Prostaglandin E2 raises the thermostatic set-point | Fever responds to aspirin and ibuprofen by blocking cyclo-oxygenase |
| Acute-phase response | Hepatic C-reactive protein, serum amyloid A, fibrinogen and hepcidin | Complement activation and iron sequestration; a raised erythrocyte sedimentation rate from fibrinogen | A CRP and ESR rise is the laboratory signature of innate activation |
Watch outFever is not a failure of temperature regulation — it is a raised set-point, and the chills that follow are thermogenesis at work. Fever is therefore a sign to investigate, not automatically a symptom to suppress, and the commonest bedside error is to give an antipyretic before a blood culture is drawn, because paracetamol can transiently sterilise culture yield and conceal bacteraemia.
Common mistakes
Watch outDescribing innate immunity as 'non-specific'. It is specific in the sense that a receptor binds a defined molecular structure; it is indiscriminate in the sense that it cannot distinguish between members of a species — any LPS is recognised by TLR4, whatever the organism. The accurate statement is 'specific for conserved molecular patterns, not for antigenic determinants'.
Watch outLocating natural killer cells inside adaptive immunity because they are effector cells. They are innate lymphocytes: they need no prior antigen exposure, they do not rearrange antigen-receptor genes, and they respond to a missing-self signal rather than a presented antigen.
Watch outThinking complement always works by lysis. For most Gram-positive organisms, opsonisation by C3b and inflammation from C5a matter far more than the membrane attack complex, which cannot pass through a thick peptidoglycan wall. Deficiency of C5, C6, C7, C8 or C9 produces a narrow phenotype — recurrent Neisseria — precisely because other routes do the rest of the work.
Check your understanding
Why is lipopolysaccharide an ideal signature for innate immunity to detect?
A patient has recurrent episodes of meningococcal septicaemia. Complement screening shows low CH50. Which components should be measured and why?
Why do viruses that downregulate MHC class I become vulnerable to natural killer cells?
Multiple choice
Which pairing of Toll-like receptor and ligand is correct?
A patient has recurrent Neisseria meningitidis sepsis, a low CH50, and normal C3 and C4. Which defect is most likely?
A child with X-linked chronic granulomatous disease is infected with a catalase-negative organism. Which mechanism is defective, and why may the infection be less severe than with a catalase-positive one?
Summary and next
Innate immunity responds in minutes, is encoded by germline genes, and is specific for conserved microbial patterns rather than antigenic determinants: TLR4 for lipopolysaccharide, TLR5 for flagellin, TLR3 for double-stranded RNA, NOD for peptidoglycan. It acts through the complement cascade — classical, lectin and alternative entry to a common terminal — by opsonisation, anaphylatoxin inflammation and the membrane attack complex; through neutrophil, macrophage and dendritic-cell phagocytosis; and through natural killer cell killing on the missing-self principle. Failure of the late complement pathway gives recurrent Neisseria disease, which is one of the most useful facts in clinical immunology.
Next: humoral adaptive immunity. You will move from the innate system that sees a category to the one that sees a molecule: B-cell activation, the five antibody classes with their very different distributions and functions, affinity maturation, and how to read a serology report.